6/17
07:00 am
prok
ProKidney Announces the Closing of $140 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering, Including Exercise of Underwriters’ Option
Low
Report
ProKidney Announces the Closing of $140 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering, Including Exercise of Underwriters’ Option
6/12
03:06 pm
prok
ProKidney surges 18% following pricing of upsized $130M stock offering [Seeking Alpha]
High
Report
ProKidney surges 18% following pricing of upsized $130M stock offering [Seeking Alpha]
6/11
09:35 pm
prok
ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering
High
Report
ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering
6/10
04:34 pm
prok
ProKidney Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering [Yahoo! Finance]
Medium
Report
ProKidney Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering [Yahoo! Finance]
6/10
04:31 pm
prok
ProKidney proposes $125M public offering of class A ordinary shares [Seeking Alpha]
Medium
Report
ProKidney proposes $125M public offering of class A ordinary shares [Seeking Alpha]
6/10
04:15 pm
prok
ProKidney Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering
High
Report
ProKidney Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering
6/10
03:14 pm
prok
ProKidney Corp. (NASDAQ: PROK) had its price target lowered by analysts at Jefferies Financial Group Inc. from $15.00 to $6.00. They now have a "buy" rating on the stock.
Medium
Report
ProKidney Corp. (NASDAQ: PROK) had its price target lowered by analysts at Jefferies Financial Group Inc. from $15.00 to $6.00. They now have a "buy" rating on the stock.
6/10
06:44 am
prok
ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and Operational Updates [Yahoo! Finance]
High
Report
ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and Operational Updates [Yahoo! Finance]
6/10
06:30 am
prok
ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and Operational Updates
Medium
Report
ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and Operational Updates
5/29
08:01 am
prok
ProKidney Corp. (NASDAQ: PROK) had its price target raised by analysts at Bank of America Co. from $3.00 to $4.00. They now have a "neutral" rating on the stock.
Medium
Report
ProKidney Corp. (NASDAQ: PROK) had its price target raised by analysts at Bank of America Co. from $3.00 to $4.00. They now have a "neutral" rating on the stock.
5/29
07:00 am
prok
ProKidney to Participate in the Jefferies Global Healthcare Conference
Medium
Report
ProKidney to Participate in the Jefferies Global Healthcare Conference
5/21
07:13 am
prok
ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024 [Yahoo! Finance]
Medium
Report
ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024 [Yahoo! Finance]
5/21
07:00 am
prok
ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024
Medium
Report
ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024
5/11
11:04 am
prok
We're Hopeful That ProKidney (NASDAQ:PROK) Will Use Its Cash Wisely [Yahoo! Finance]
Medium
Report
We're Hopeful That ProKidney (NASDAQ:PROK) Will Use Its Cash Wisely [Yahoo! Finance]
5/10
07:03 am
prok
ProKidney Reports Business Updates and First Quarter 2024 Financial Results [Yahoo! Finance]
High
Report
ProKidney Reports Business Updates and First Quarter 2024 Financial Results [Yahoo! Finance]
5/10
07:00 am
prok
ProKidney Reports Business Updates and First Quarter 2024 Financial Results
Medium
Report
ProKidney Reports Business Updates and First Quarter 2024 Financial Results
4/25
10:50 am
prok
Diabetic Kidney Disease (DKD) - Market Insight, Epidemiology and Market Forecast - 2032 [Yahoo! Finance]
Medium
Report
Diabetic Kidney Disease (DKD) - Market Insight, Epidemiology and Market Forecast - 2032 [Yahoo! Finance]
4/22
10:06 am
prok
Lexicon Pharmaceuticals, Bio-Path Holdings, Protara Therapeutics among healthcare movers [Seeking Alpha]
High
Report
Lexicon Pharmaceuticals, Bio-Path Holdings, Protara Therapeutics among healthcare movers [Seeking Alpha]
4/1
05:35 pm
prok
Diabetic Kidney Disease Market to Witness Upsurge in Growth at a CAGR of ~6.5% by 2034 | DelveInsight [Yahoo! Finance]
Medium
Report
Diabetic Kidney Disease Market to Witness Upsurge in Growth at a CAGR of ~6.5% by 2034 | DelveInsight [Yahoo! Finance]
3/25
06:25 am
prok
ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations [Yahoo! Finance]
Low
Report
ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations [Yahoo! Finance]
3/25
06:05 am
prok
ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations
Low
Report
ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations